摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-methoxy-3-{5-[(4-methylpiperazin-1-yl)methyl]-3-furyl}-phenyl)amine | 846023-60-7

中文名称
——
中文别名
——
英文名称
(4-methoxy-3-{5-[(4-methylpiperazin-1-yl)methyl]-3-furyl}-phenyl)amine
英文别名
(4-methoxy-3-{5-[(4-methylpiperazin-1-yl)methyl]-furan-3-yl}phenyl)amine;(4-Methoxy-3-[5-[(4-methylpiperazin-1-yl)methyl]-3-furyl}phenyl)amine;4-methoxy-3-[5-[(4-methylpiperazin-1-yl)methyl]furan-3-yl]aniline
(4-methoxy-3-{5-[(4-methylpiperazin-1-yl)methyl]-3-furyl}-phenyl)amine化学式
CAS
846023-60-7
化学式
C17H23N3O2
mdl
——
分子量
301.389
InChiKey
KTURLICKYYNFBQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    432.9±45.0 °C(Predicted)
  • 密度:
    1.153±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    54.9
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:49079deca6e9c13ed833a29fbf96dc54
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and Src Kinase Inhibitory Activity of a Series of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles
    摘要:
    Compound 1 (SKI-606, bosutinib), a 7-alkoxy-4-[(2,4-dichloro-5-methoxyphenyl)amino]-3-quinolinecarbonitrile, is a potent inhibitor of Src kinase activity. We previously reported that analogs of 1 with thiophene groups at C-7 retained the Src activity of the parent compound. The corresponding C-7 furan analogs were prepared and it was found that the 3,5-substituted furan analog had increased activity compared to that of the 2,5-substituted furan isomer. Addition of a methoxy group at C-6 decreased the Src inhibitory activity of the C-7 2,5-substituted furan analog but increased the activity of the C-7 3,5-substituted furan isomer. This compound, 10, was a more potent Src inhibitor than 1 in both enzymatic and cell-based assays. The kinase selectivity profile of 10 was similar to that of 1, with 10 also inhibiting the activity of Abl and Lck. When tested in a solid tumor xenograft model, 10 had comparable oral activity to that of 1.
    DOI:
    10.1021/jm061031t
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Src Kinase Inhibitory Activity of a Series of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles
    摘要:
    Compound 1 (SKI-606, bosutinib), a 7-alkoxy-4-[(2,4-dichloro-5-methoxyphenyl)amino]-3-quinolinecarbonitrile, is a potent inhibitor of Src kinase activity. We previously reported that analogs of 1 with thiophene groups at C-7 retained the Src activity of the parent compound. The corresponding C-7 furan analogs were prepared and it was found that the 3,5-substituted furan analog had increased activity compared to that of the 2,5-substituted furan isomer. Addition of a methoxy group at C-6 decreased the Src inhibitory activity of the C-7 2,5-substituted furan analog but increased the activity of the C-7 3,5-substituted furan isomer. This compound, 10, was a more potent Src inhibitor than 1 in both enzymatic and cell-based assays. The kinase selectivity profile of 10 was similar to that of 1, with 10 also inhibiting the activity of Abl and Lck. When tested in a solid tumor xenograft model, 10 had comparable oral activity to that of 1.
    DOI:
    10.1021/jm061031t
点击查看最新优质反应信息

文献信息

  • Process for preparation of 4-amino-3-quinolinecarbonitriles
    申请人:Sutherland Wiggins Karen
    公开号:US20050043537A1
    公开(公告)日:2005-02-24
    This invention discloses a process for the preparation of a 4-amino-3-quinolinecarbonitrile comprising combining an amine compound with a cyanoacetic acid and an acid catalyst to yield a cyanoacetamide; condensing the cyanoacetamide with an optionally up to tetra-substituted aniline in an alcoholic solvent and a trialkylorthoformate to yield a 3-amino-2-cyanoacrylamide; combining the 3-amino-2-cyanoacrylamide with phosphorus oxychloride in acetonitrile, butyronitrile, toluene or xylene, optionally in the presence of a catalyst to yield a 4-amino-3-quinolinecarbonitrile and also discloses a process for the preparation of a 7-amino-thieno[3,2-b]pyridine-6-carbonitrile comprising combining a disubstituted 3-amino thiophene with a cyanoacetamide and trialkylorthoformate in an alcoholic solvent to obtain a 3-amino-2-cyanoacrylamide; and combining the 3-amino-2-cyanoacrylamide with phosphorus oxychloride and acetonitrile, butyronitrile, toluene or xylene, optionally in the presence of a catalyst to yield a 7-amino-thieno[3,2-b]pyridine-6-carbonitrile and also discloses a process for the preparation of a 4-amino-3-quinolinecarbonitrile by combining an amine compound with a cyanoacetic acid and a peptide coupling reagent to obtain a suspension; filtering the suspension to yield a cyanoacetamide; condensing the cyanoacetamide with an optionally up to tetra-substituted aniline, an alcoholic solvent, and triethylorthoformate to yield a 3-amino-2-cyanoacrylamide; and combining the 3-amino-2-cyanoacrylamide with phosphorus oxychloride to yield a 4-amino-3-quinolinecarbonitrile.
    这项发明揭示了一种制备4-基-3-喹啉碳腈的过程,包括将胺化合物与氰乙酸和酸催化剂结合以产生乙酰胺;将乙酰胺与醇溶剂和三烷基正甲酸酯中的一个或多个取代苯胺缩合以产生3-基-2-丙烯酰胺;将3-基-2-丙烯酰胺与乙腈丁腈甲苯或二甲苯中结合,可选地在催化剂存在的情况下以产生4-基-3-喹啉碳腈,并且还揭示了一种制备7-噻吩[3,2-b]吡啶-6-碳腈的过程,包括将二取代的3-氨基噻吩乙酰胺和三烷基正甲酸酯在醇溶剂中结合以获得3-基-2-丙烯酰胺;将3-基-2-丙烯酰胺与乙腈丁腈甲苯或二甲苯结合,可选地在催化剂存在的情况下以产生7-噻吩[3,2-b]吡啶-6-碳腈,并且还揭示了一种通过将胺化合物与氰乙酸和肽偶联试剂结合以获得悬浮液;过滤悬浮液以产生乙酰胺;将乙酰胺与一个或多个取代苯胺、醇溶剂和三乙基正甲酸酯缩合以产生3-基-2-丙烯酰胺;将3-基-2-丙烯酰胺与结合以产生4-基-3-喹啉碳腈的制备过程。
  • [EN] PROCESS FOR THE PREPARATION OF 4-AMINO-3-QUINOLINECARBONITRILES<br/>[FR] PROCEDE DE PREPARATION DE 4-AMINO-3-QUINOLEINECARBONITRILES
    申请人:WYETH CORP
    公开号:WO2005019201A2
    公开(公告)日:2005-03-03
    This invention discloses a process for the preparation of a 4-amino-3quinolinecarbonitrile comprising combining an amine compound with a cyanoacetic acid and an acid catalyst to yield a cyanoacetamide; condensing the cyanoacetamide with an optionally up-to tetra-substituted aniline in an alcoholic solvent and a trialkylorthoformate to yield an 2-amino-2-cyanoacrylamide; combining the 3-amino2-cyanoacrylamide with phosphorus oxychloride in acetonitrile, butyronitrile, toluene or xylene, optionally in the presence of a catalyst to yield a 4-amino-3quinolinecarbonitrile and also discloses a process for the preparation of a 7-amino-thieno[3,2-b]pyridine­6-carbonitrile comprising combining a 3-amino thiophene with a cyanoacetamide and trial kylorthoformate in an alcoholic solvent to obtain a 3-amino2-cyanoacrylamide; and combining the 3-amino-2-cyanoacrylamide with phosphorus oxychloride and acetonitrile, butyronitrile, toluene or xylene, optionally in the presence of a catalyst to yield a 7-amino-thieno[3,2-b]pyridine-6-carbonitrile and also discloses a process for the preparation of a 4 amino-3-quinolinecarbonitrile comprising: combining an amine compound with cyanoacetic acid and a peptide coupling reagent to obtain a suspension; filtering the suspension; to yield cyanoacetamide; condensing the cyanoacetamide with an optionally up to tetra-substituted aniline with an alcoholic solvent to yield a 4-amino-3-quinolinecarbonitrile, and the invention discloses a process for obtaining a cyanoacetamide.
    本发明公开了一种制备4-基-3-喹啉羧腈的方法,包括将胺化合物与氰乙酸和酸催化剂结合以得到乙酰胺;将乙酰胺与可选的高达四取代苯胺在醇溶剂和三烷基正酸酐中缩合,以得到2-基-2-丙烯酰胺;将3-基-2-丙烯酰胺与氧化乙腈丁腈甲苯或二甲苯中结合,可选地在催化剂的存在下,以得到4-基-3-喹啉羧腈。本发明还公开了一种制备7-噻吩[3,2-b]吡啶-6-羧腈的方法,包括将3-氨基噻吩乙酰胺和三烷基正酸酐在醇溶剂中结合以得到3-基-2-丙烯酰胺;将3-基-2-丙烯酰胺与氧化乙腈丁腈甲苯或二甲苯结合,可选地在催化剂的存在下,以得到7-噻吩[3,2-b]吡啶-6-羧腈。本发明还公开了一种制备4-基-3-喹啉羧腈的方法,包括将胺化合物与氰乙酸和肽偶联试剂结合以得到悬浮液;过滤悬浮液以得到乙酰胺;将乙酰胺与可选的高达四取代苯胺在醇溶剂中缩合,以得到4-基-3-喹啉羧腈。本发明还公开了一种获得乙酰胺的方法。
  • PROCESS FOR THE PREPARATION OF 4-AMINO-3-QUINOLINECARBONITRILES
    申请人:Wyeth Holdings Corporation
    公开号:EP1660453A2
    公开(公告)日:2006-05-31
  • US7297795B2
    申请人:——
    公开号:US7297795B2
    公开(公告)日:2007-11-20
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯